Peter H. O'Donnell to Double-Blind Method
This is a "connection" page, showing publications Peter H. O'Donnell has written about Double-Blind Method.
Connection Strength
0.042
-
Atezolizumab plus chemotherapy versus placebo plus chemotherapy in untreated locally advanced or metastatic urothelial carcinoma (IMvigor130): final overall survival analysis results from a randomised, controlled, phase 3 study. Lancet Oncol. 2024 Jan; 25(1):29-45.
Score: 0.042